Table 2.

The association between hyperuricemia and MAFLD by the logistic regression in the cross-sectional study.

	OR (95%CI)	P-value
Crude	3.484 (3.451, 3.518)	<0.001
Model 1	2.931 (2.902, 2.960)	<0.001
Model 2	2.048 (2.026, 2.070)	<0.001

MAFLD, metabolic dysfunction-associated fatty liver disease.

Model 1: adjusted for age and sex.

Model 2: adjusted for age, sex, low-density lipoprotein cholesterol (LDL-C), fasting blood glucose (FBG), alanine aminotransferase (ALT), blood urea nitrogen (BUN), systolic blood pressure (SBP), triglycerides (TG).